HEATHER MEEUSEN: Open Payments
NPI 1205212214 · PLYMOUTH, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 26 payments from 10 companies in 2025. Trend: 2023 $325 · 2024 $473 · 2025 $913
Food & beverage: $576Travel & lodging: $337
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 8 | $582 |
| Ascendis Pharma Endocrinology Inc | 4 | $89 |
| Insulet Corporation | 4 | $68 |
| Amgen Inc. | 2 | $43 |
| Tandem Diabetes Care, Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $30 |
| Ascensia Diabetes Care Us Inc. | 1 | $17 |
| Sequel Med Tech, LLC | 1 | $16 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $14 |
Products named: MINIMED 780G, Yorvipath, Omnipod, TEPEZZA, t:slim X2 Insulin Pump with Control-IQ, TWIIST, Wegovy, ISTURISA.
Industry payments across WI — which companies pay providers there.
